Outset Medical Stock Analysis
| OM Stock | USD 5.01 0.06 1.18% |
IPO Date 15th of September 2020 | 200 Day MA 12.5722 | 50 Day MA 4.4267 | Beta 2.067 |
Outset Medical holds a debt-to-equity ratio of 0.132. At this time, Outset Medical's Debt To Assets are very stable compared to the past year. As of the 1st of February 2026, Long Term Debt To Capitalization is likely to grow to 0.83, while Long Term Debt Total is likely to drop about 57.1 M. Outset Medical's financial risk is the risk to Outset Medical stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Outset Medical's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Outset Medical's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Outset Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Outset Medical's stakeholders.
For most companies, including Outset Medical, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Outset Medical, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Outset Medical's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 0.6638 | Enterprise Value Ebitda (0.24) | Price Sales 0.7575 | Shares Float 10.3 M | Wall Street Target Price 11.75 |
Outset Medical is undervalued with Real Value of 6.49 and Target Price of 11.75. The main objective of Outset Medical stock analysis is to determine its intrinsic value, which is an estimate of what Outset Medical is worth, separate from its market price. There are two main types of Outset Medical's stock analysis: fundamental analysis and technical analysis.
The Outset Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Outset Medical is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Outset Stock trading window is adjusted to America/New York timezone.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Outset Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. Outset Stock Analysis Notes
About 97.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.66. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Outset Medical has Price/Earnings To Growth (PEG) ratio of 0.06. The entity recorded a loss per share of 11.56. The firm had not issued any dividends in recent years. Outset Medical had 1:15 split on the 20th of March 2025. Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Outset Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 444 people. To find out more about Outset Medical contact Leslie Trigg at 669 231 8200 or learn more at https://www.outsetmedical.com.Outset Medical Quarterly Total Revenue |
|
Outset Medical Investment Alerts
| Outset Medical generated a negative expected return over the last 90 days | |
| Outset Medical has high historical volatility and very poor performance | |
| Outset Medical has a very high chance of going through financial distress in the upcoming years | |
| The company generated the yearly revenue of 113.69 M. Annual Net Loss to common stockholders was (127.98 M) with gross profit of 45.32 M. | |
| Outset Medical reports about 227.52 M in cash with (116.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.71. | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System - Nasdaq |
Outset Largest EPS Surprises
Earnings surprises can significantly impact Outset Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-11-03 | 2021-09-30 | -0.73 | -0.65 | 0.08 | 10 | ||
2021-03-09 | 2020-12-31 | -0.66 | -0.75 | -0.09 | 13 | ||
2022-02-16 | 2021-12-31 | -0.77 | -0.87 | -0.1 | 12 |
Outset Medical Environmental, Social, and Governance (ESG) Scores
Outset Medical's ESG score is a quantitative measure that evaluates Outset Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Outset Medical's operations that may have significant financial implications and affect Outset Medical's stock price as well as guide investors towards more socially responsible investments.
Outset Medical Thematic Classifications
In addition to having Outset Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | DrugsDrug manufacturing and delivery |
Outset Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Marshall Wace Asset Management Ltd | 2025-06-30 | 521.4 K | Pura Vida Investments, Llc | 2025-06-30 | 429.1 K | Geode Capital Management, Llc | 2025-06-30 | 415.6 K | Ensign Peak Advisors Inc | 2025-06-30 | 314.5 K | Schonfeld Strategic Advisors Llc | 2025-06-30 | 256.7 K | Northern Trust Corp | 2025-06-30 | 249.4 K | State Street Corp | 2025-06-30 | 205.3 K | Catalio Capital Management, Lp | 2025-06-30 | 166.7 K | Millennium Management Llc | 2025-06-30 | 158.5 K | Fmr Inc | 2025-06-30 | 2.6 M | Partner Fund Management Lp | 2025-06-30 | 1.7 M |
Outset Market Capitalization
The company currently falls under 'Micro-Cap' category with a market capitalization of 90.95 M.Outset Profitablity
The company has Net Profit Margin (PM) of (0.73) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.54) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.54.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.53) | (0.56) | |
| Return On Capital Employed | (0.44) | (0.46) | |
| Return On Assets | (0.53) | (0.56) | |
| Return On Equity | (5.49) | (5.21) |
Management Efficiency
Outset Medical has Return on Asset (ROA) of (0.1525) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1525. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.9233) %, which implies that it produced no returns to current stockholders. Outset Medical's management efficiency ratios could be used to measure how well Outset Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of February 2026, Return On Tangible Assets is likely to drop to -0.56. In addition to that, Return On Capital Employed is likely to drop to -0.46. At this time, Outset Medical's Fixed Asset Turnover is very stable compared to the past year. As of the 1st of February 2026, Asset Turnover is likely to grow to 0.39, while Other Current Assets are likely to drop about 4.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 6.97 | 3.52 | |
| Tangible Book Value Per Share | 6.97 | 3.52 | |
| Enterprise Value Over EBITDA | (1.25) | (1.31) | |
| Price Book Value Ratio | 1.94 | 1.27 | |
| Enterprise Value Multiple | (1.25) | (1.31) | |
| Price Fair Value | 1.94 | 1.27 | |
| Enterprise Value | 386.3 M | 367 M |
Outset Medical has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Technical Drivers
As of the 1st of February, Outset Medical holds the Risk Adjusted Performance of (0.09), variance of 69.97, and Coefficient Of Variation of (722.54). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Outset Medical, as well as the relationship between them. Please check Outset Medical risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Outset Medical is priced some-what accurately, providing market reflects its current price of 5.01 per share. Given that Outset Medical has information ratio of (0.14), we recommend you to check out Outset Medical's recent market performance to make sure the company can sustain itself at a future point.Outset Medical Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Outset Medical price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
Outset Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Outset Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Outset Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Outset Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Outset Medical Outstanding Bonds
Outset Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Outset Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Outset bonds can be classified according to their maturity, which is the date when Outset Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Outset Medical Predictive Daily Indicators
Outset Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Outset Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Outset Medical Corporate Filings
8K | 27th of January 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 21st of January 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of January 2026 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 12th of January 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 8th of January 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 2nd of December 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 18th of November 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2025 An amended filing to the original Schedule 13G | ViewVerify |
Outset Medical Forecast Models
Outset Medical's time-series forecasting models are one of many Outset Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Outset Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Outset Medical Bond Ratings
Outset Medical financial ratings play a critical role in determining how much Outset Medical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Outset Medical's borrowing costs.| Piotroski F Score | 5 | Healthy | View |
| Beneish M Score | (2.93) | Unlikely Manipulator | View |
Outset Medical Debt to Cash Allocation
Many companies such as Outset Medical, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Outset Medical reports 201.86 M of total liabilities with total debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from financial leverage. Outset Medical has a current ratio of 6.12, indicating that it is in good position to pay out its debt commitments in time. That said, strategic use of leverage may enable Outset to fund expansion initiatives and generate superior returns. Outset Medical Total Assets Over Time
Outset Medical Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Outset Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Outset Medical Debt Ratio | 69.0 |
Outset Medical Corporate Bonds Issued
Outset Short Long Term Debt Total
Short Long Term Debt Total |
|
About Outset Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Outset Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Outset shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Outset Medical. By using and applying Outset Stock analysis, traders can create a robust methodology for identifying Outset entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (1.01) | (1.06) | |
| Operating Profit Margin | (0.90) | (0.94) | |
| Net Loss | (1.01) | (1.06) | |
| Gross Profit Margin | 0.31 | 0.32 |
Current Outset Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Outset analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Outset analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 11.75 | Strong Buy | 5 | Odds |
Most Outset analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Outset stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Outset Medical, talking to its executives and customers, or listening to Outset conference calls.
Outset Stock Analysis Indicators
Outset Medical stock analysis indicators help investors evaluate how Outset Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Outset Medical shares will generate the highest return on investment. By understating and applying Outset Medical stock analysis, traders can identify Outset Medical position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 71.8 M | |
| Long Term Debt | 197.4 M | |
| Common Stock Shares Outstanding | 3.5 M | |
| Total Stockholder Equity | 26.8 M | |
| Total Cashflows From Investing Activities | 103.9 M | |
| Tax Provision | 491 K | |
| Property Plant And Equipment Net | 12.1 M | |
| Cash And Short Term Investments | 158.7 M | |
| Cash | 124 M | |
| Accounts Payable | 3.9 M | |
| Net Debt | 77.8 M | |
| 50 Day M A | 4.4267 | |
| Total Current Liabilities | 45.4 M | |
| Other Operating Expenses | 227.1 M | |
| Non Current Assets Total | 17.6 M | |
| Non Currrent Assets Other | 5.5 M | |
| Stock Based Compensation | 29.4 M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Outset Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Will Health Care Equipment & Supplies sector continue expanding? Could Outset diversify its offerings? Factors like these will boost the valuation of Outset Medical. Anticipated expansion of Outset directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Outset Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (11.56) | Revenue Per Share | Quarterly Revenue Growth 0.027 | Return On Assets | Return On Equity |
Outset Medical's market price often diverges from its book value, the accounting figure shown on Outset's balance sheet. Smart investors calculate Outset Medical's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Outset Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Outset Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Outset Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Outset Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
